Study Shows GLP-1 Drugs Could Be Linked to Lower Addiction Risk

Narrative A

It's an extremely positive development that these drugs quiet the relentless craving that drives addiction by targeting shared reward pathways in the brain, offering hope where decades-old treatments have failed miserably. This isn't about willpower anymore; it's about treating addiction as the chronic biological disease it actually is.